Literature DB >> 12394961

Early immunoneutralization of calcitonin precursors attenuates the adverse physiologic response to sepsis in pigs.

Kristin E Wagner1, Jose M Martinez, Steven D Vath, Richard H Snider, Eric S Nylén, Kenneth L Becker, Beat Müller, Jon C White.   

Abstract

OBJECTIVE: The 116 amino acid prohormone procalcitonin and some of its component peptides (collectively termed calcitonin precursors) are important markers and mediators of sepsis. In this study, we sought to evaluate the effect of immunoneutralization of calcitonin precursors on metabolic and physiologic variables of sepsis in a porcine model.
DESIGN: A prospective, controlled animal study.
SETTING: A university research laboratory.
SUBJECTS: 30-kg Yorkshire pigs.
INTERVENTIONS: Sepsis was induced in 15 pigs by intraperitoneal instillation of a suspension of cecal content (1 g/kg animal body weight) and a toxinogenic Escherichia coli solution (2 x 10(11) colony-forming units). During induction of sepsis, seven pigs received an intravenous infusion of purified rabbit antiserum, reactive to the aminoterminal portion of porcine prohormone procalcitonin. Another eight control pigs received an intravenous infusion of purified nonreactive rabbit antiserum. For all 15 animals, physiologic data (urine output, core temperature, arterial pressure, heart rate, cardiac index, and stroke volume index) and metabolic data (serum blood urea nitrogen and creatinine, arterial lactate, and pH) were collected or recorded hourly until death at 15 hrs.
MEASUREMENTS AND MAIN RESULTS: In this large-animal model of rapidly lethal peritonitis, serum calcitonin precursors were significantly elevated. Amino-prohormone procalcitonin-reactive antiserum administration resulted in a significant improvement or a beneficial trend in a majority of the measured physiologic and metabolic derangements induced by sepsis. Specifically, arterial pressure, cardiac index, stroke volume index, pH, and creatinine were all significantly improved, while urine output and serum lactate had beneficial trends. Treated animals also experienced a statistically significant increase of short-term survival.
CONCLUSIONS: These data from a large-animal model with polymicrobial sepsis demonstrate the salutary effect of early immunoneutralization of calcitonin precursors on physiologic and metabolic variables. Immunologic blockade of calcitonin precursors may offer a novel therapeutic approach to human sepsis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12394961     DOI: 10.1097/00003246-200210000-00021

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  18 in total

Review 1.  Immune regulation of procalcitonin: a biomarker and mediator of infection.

Authors:  G N Matwiyoff; J D Prahl; R J Miller; J J Carmichael; D E Amundson; G Seda; M Daheshia
Journal:  Inflamm Res       Date:  2012-02-22       Impact factor: 4.575

2.  Procalcitonin induced cytotoxicity and apoptosis in mesangial cells: implications for septic renal injury.

Authors:  Magali Araujo; Sonia Q Doi; Carlos E Palant; Eric S Nylen; Kenneth L Becker
Journal:  Inflamm Res       Date:  2013-07-20       Impact factor: 4.575

Review 3.  Procalcitonin: present and future.

Authors:  H H Liu; J B Guo; Y Geng; L Su
Journal:  Ir J Med Sci       Date:  2015-07-10       Impact factor: 1.568

Review 4.  Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target.

Authors:  Kenneth L Becker; Richard Snider; Eric S Nylen
Journal:  Br J Pharmacol       Date:  2009-11-27       Impact factor: 8.739

Review 5.  Overview of procalcitonin in pregnancy and in pre-eclampsia.

Authors:  A Mangogna; C Agostinis; G Ricci; F Romano; R Bulla
Journal:  Clin Exp Immunol       Date:  2019-06-13       Impact factor: 4.330

6.  Intravenous immunoglobulin prevents release of proinflammatory cytokines in human monocytic cells stimulated with procalcitonin.

Authors:  Kazuki Murakami; Chiaki Suzuki; Akihiro Fujii; Teruaki Imada
Journal:  Inflamm Res       Date:  2012-02-22       Impact factor: 4.575

7.  Procalcitonin predicts mortality in HIV-infected Ugandan adults with lower respiratory tract infections.

Authors:  Sofya Tokman; Christopher F Barnett; Leah G Jarlsberg; Pam R Taub; Saskia den Boon; J Lucian Davis; Adithya Cattamanchi; William Worodria; Alan Maisel; Laurence Huang
Journal:  Respirology       Date:  2014-01-26       Impact factor: 6.424

8.  Deletion of the gene encoding calcitonin and calcitonin gene-related peptide α does not affect the outcome of severe infection in mice.

Authors:  Michael J Tuvim; Cecilia G Clement; Eileen Su-Chen Huang; Gilbert J Cote; Scott E Evans; Xiudong Lei; Leonard J Deftos; Robert F Gagel; Burton F Dickey
Journal:  Am J Respir Cell Mol Biol       Date:  2013-07       Impact factor: 6.914

Review 9.  Procalcitonin: improved biochemical severity stratification and postoperative monitoring in severe abdominal inflammation and sepsis.

Authors:  B Rau; C M Krüger; M K Schilling
Journal:  Langenbecks Arch Surg       Date:  2004-03-06       Impact factor: 3.445

10.  Procalcitonin levels predict acute kidney injury and prognosis in acute pancreatitis: a prospective study.

Authors:  Hua-Lan Huang; Xin Nie; Bei Cai; Jiang-Tao Tang; Yong He; Qiang Miao; Hao-Lan Song; Tong-Xing Luo; Bao-Xiu Gao; Lan-Lan Wang; Gui-Xing Li
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.